Edition:
United Kingdom

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.17USD
12 Dec 2017
Change (% chg)

$-0.05 (-4.10%)
Prev Close
$1.22
Open
$1.23
Day's High
$1.23
Day's Low
$1.13
Volume
222,921
Avg. Vol
162,639
52-wk High
$3.91
52-wk Low
$0.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 0.00 -0.531
Jun 0.00 -0.278
FY 2017 Mar '17 0.00 -0.325
Dec 1.25 -0.343
Sep 0.00 -0.416
Jun 0.00 -0.514
FY 2016 Mar '16 0.00 -4.445
Dec 0.00 -1.952
Sep 0.00 -5.263
Jun 0.00 -19.233
FY 2015 Mar '15 0.00 -4.250
Dec 0.00 -0.837
Sep 0.00 -1.580
Jun 0.00 -3.704
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-17 2 0.00 0.00 0.00 --
Year Ending Mar-17 2 1.25 1.25 1.25 --
Earnings (per share)
Quarter Ending Mar-17 2 -0.50 -0.49 -0.52 --
Year Ending Mar-17 2 -1.76 -1.73 -1.79 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta -0.57 0.90 0.88
Price to Sales (TTM) 13.68 3.93 5.40
Price to Book (MRQ) -- 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 18.15 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 4.66 5.38
Sales - 5 Yr. Growth Rate -1.41 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.84 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 88.82 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 49.14 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 2.12 2.88 2.98
LT Debt to Equity (MRQ) -- 9.47 11.56
Total Debt to Equity (MRQ) -- 13.43 15.81
Interest Coverage (TTM) -5,804.00 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -838.44 -- --
EBITD - 5 Yr. Avg -3,202.01 18.46 15.24
Operating Margin (TTM) -843.66 14.50 7.76
Operating Margin - 5 Yr. Avg. -5,471.17 14.42 10.75
Pre-Tax Margin (TTM) -844.10 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -6,012.32 14.74 11.17
Net Profit Margin (TTM) -844.30 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -6,013.25 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,213,833 864,673,366
Net Income/Employee (TTM) -- 112,151,384 101,717,513
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.22 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -188.55 11.42 11.00
Return on Assets - 5 Yr. Avg. -1,968.05 13.00 12.43
Return on Investment (TTM) -245.77 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) -415.24 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -- -- -1.41
EPS (TTM) % 94.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for VistaGen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.03%
# of Holders: 15
Total Shares Held: 2,460,559
3 Mo. Net Change: 509,387
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 3
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.